Prospective Cohort Study of Trastuzumab Biosimilar CT-P6 in HER2-Positive Gastric Cancer: Japanese Real-World OutcomesAuthorsTatsuji HanejiKiyohiro Nishikawa (ORCID: https://orcid.org/0000-0003-2350-6189)Hiroya Taniguchi (ORCID: https://orcid.org/0000-0003-1407-6682)Hironori Yamaguchi (ORCID: https://orcid.org/0000-0002-8371-9410)Hiroshi Imamura (ORCID: https://orcid.org/0000-0002-4294-6289)Naoki IzawaInstitutionsJichi Medical University (JP)St. Marianna University School of Medicine (JP)Toyonaka Municipal Hospital (JP)Nishikawa Hospital (JP)Aichi Cancer Center (JP)Nippon Kayaku (Japan) (JP)Publication DetailsJournalOncology and TherapyPublished2025-05-08DOIhttps://doi.org/10.1007/s40487-025-00341-7Primary TopicHER2/EGFR in Cancer ResearchTypearticleField-Weighted Citation Impact0.00FundersNippon KayakuExplore the Global Research Space Interactive Map